Similar Articles |
|
Pharmaceutical Executive June 1, 2007 Cook & Leiken |
Legal: Foreign Policy Drug companies doing business abroad face a special risk of running afoul of stepped-up enforcement of anticorruption laws. |
National Defense August 2010 Patrick & Renzulli |
Defense Contractors Increasingly Targeted in Corruption Investigations Companies and individuals are facing dramatically higher penalties and costs for failing to comply with anti-bribery laws around the world, and especially in the United States. |
National Defense September 2005 Shaheen & Geren |
Penalties Get Tougher For FCPA Violations The government is cracking down on bribes by government contractors to foreign officials. |
National Defense November 2011 Piazza & Ayers |
Regulators Flex Foreign Corrupt Practices Act Enforcement Muscles Continuing a trend that started late in the last decade, the Securities and Exchange Commission this year continues to raise the bar on the enforcement of the Foreign Corrupt Practices Act of 1977. |
National Defense September 2015 Kopp & Bhatia |
U.S. Cracking Down on Defense Industry Corruption Overseas The race for international sales during the past few years has been followed by a wave of government investigations into defense companies for both major and relatively minor violations of the Foreign Corrupt Practices Act. |
National Defense July 2010 Anderson & Goodwin |
Anti-Bribery Case in China a Wake-Up Call The recent Rio Tinto case in China is a powerful reminder why a vigilant and robust Foreign Corrupt Practices Act of 1977 (FCPA) corporate compliance program is important. |
National Defense November 2015 Bradel & Ralph |
Justice Memo Calls for Absolute Cooperation The Foreign Corrupt Practices Act is a statute aimed at eliminating corporate bribery of foreign government officials. A defense contractor doing work overseas must be familiar with its tenets. |
CFO September 1, 2008 Kate O'Sullivan |
Gunning for Global Graft The Department of Justice and the SEC turn up the heat on briberies of foreign officials. |
Pharmaceutical Executive December 1, 2010 Chaturvedi & French |
US Anti-Corruption Regulation Risks Stepped-up enforcement of the Foreign Corrupt Practices Act requires enhanced global coordination of compliance |
National Defense January 2014 Cannon & Scott |
Anti-Bribery Law Demands Vigilance November marked the one-year anniversary of the release of the resource guide to the Foreign Corrupt Practices Act, and should serve to remind all defense contractors of the critical importance of keeping their compliance program current and effective. |
CFO January 1, 2005 David M. Katz |
The Bribery Gap While foreign rivals may make payoffs routinely, U.S. firms face new pressure to root out abuses. |
Chemistry World October 7, 2015 Phillip Broadwith |
Bristol-Myers-Squibb fined for alleged Chinese bribes The US Securities and Exchange Commission has fined New York based pharmaceutical company Bristol-Myers Squibb over $14 million over alleged bribes made to Chinese state owned hospitals. |
BusinessWeek July 8, 2010 Dexter Roberts |
The Higher Costs of Bribery in China The U.S. is policing the activities of big multinationals in China more aggressively, with China's own prosecutors sometimes following suit. |
National Defense July 2009 Latour & Maki |
Companies Must Resist Temptations to Cut Corners The defense industry must counter any temptation to cut corners that could result in violations of the Foreign Corrupt Practices Act (FCPA). |
Pharmaceutical Executive October 1, 2005 Andy Bender |
Orchestrating Compliance Product managers at pharmaceuticals are not always happy to see their compliance officers. That may be changing. |
IndustryWeek March 16, 2011 |
Schooled By Scandals Manufacturers burned by foreign bribery scandals provide valuable lessons for companies expanding their global presence. |
Inc. August 2007 Alison Stein Wellner |
No Free Pass Anti-bribery law is now being aggressively enforced. |
The Motley Fool November 11, 2004 Rich Smith |
SEC Targets Lucent Ex-Execs Investigation into alleged Saudi bribery by its Chinese subsidiary moves ahead. Lucent's stock has dropped 15% in value. |
National Defense February 2011 Pappalardo & Bombach |
Justice Department Beefs Up Foreign Corruption Act Enforcement Enforcement of the Foreign Corrupt Practices Act gained momentum in 2010. |
Pharmaceutical Executive January 1, 2012 |
Compliance: Getting Those Ducks in a Row Pharma must coordinate the efforts of medical, legal, HR, global partners and many other players in the regulatory compliance space to keep itself afloat in choppy seas. |
The Motley Fool January 8, 2004 Rich Smith |
Oops, I(BM) Did it Again Once again IBM finds itself embattled in bribing controversy abroad. |
National Defense December 2007 Shaheen & Reeves |
Export Laws: Avoid The Scarlett Letter Complex U.S. export control laws and regulations are here to stay. The federal government is serious about export control enforcement, and violators are being severely punished. |
CFO February 1, 2012 Sarah Johnson |
Don't Trust, Verify With antibribery actions on the rise, companies should monitor their business partners more closely than ever. |
InternetNews January 6, 2004 Colin Haley |
IBM Korea Scandal Prompts U.S. Inquiries The DOJ and SEC are reportedly looking into bribery and bid-rigging allegations against the IT giant's South Korean subsidiary. |
National Defense December 2010 O'Neill et al. |
The Long Arm Of the U.K. Bribery Act For U.S. companies, particularly those active in foreign countries or engaged in high-profile markets such as the defense industry, maintaining ethical operations and avoiding corruption is essential. |
InternetNews December 15, 2004 Tim Gray |
Time Warner Settles Fraud Case Time Warner said today that it has agreed to pay $210 million in criminal and civil fines to settle a federal fraud case stemming from allegedly shady advertising deals within its America Online division. |
National Defense January 2006 Reeder & Hickey |
Make Commitment To Corporate Ethics The National Defense Industrial Association puts ethical conduct on par with shareholder profits and believes maintaining the highest ethical standards throughout the defense industry has never been more important to the country. |
The Motley Fool January 7, 2005 Rich Smith |
Monsanto Dodges a Bullet The SEC and DOJ notch victories. Monsanto's punishment for fraud in Indonesia will be a relatively mild $1.5 million in total fines and a commitment to stay out of trouble over the next three years of probation. |
Pharmaceutical Executive September 1, 2013 Shantanu Agrawal |
Making Sense of the Sunshine Act: A New Era for Drug Promotion Now that the Sunshine Act's Open Payments spending disclosure program is live, the federal government's lead officer for compliance explains how the new web-based system will work and how US industry, providers, and patients will be better off by making their relationships fully transparent. |
Pharmaceutical Executive January 1, 2013 Ben Comer |
Compliance in the C-Suite Compliance officers have risen into pharmaceutical management's highest ranks, by choice in some organizations, and by government decree in others. Either way, their importance as a strategic partner can hardly be understated. |
CFO April 15, 2012 Sarah Johnson |
Coverage for Uncovered Secrets New insurance products will compensate companies for the costs of internal investigations. |
CFO January 1, 2008 Kate O'Sullivan |
Foreign Intelligence CFOs need to be smart about overseas operations -- or risk paying a heavy price. |
National Defense August 2006 Shaheen & Bombach |
Anti-Bribery Enforcement On the Increase Overseas U.S. government contractors involved in overseas sales recognize the need to comply with the anti-bribery provisions of the U.S. Foreign Corrupt Practices Act. |
On Wall Street October 1, 2009 Thomas O. Gorman |
SEC v. Bank of America: Where to Go From Here? The SEC thought it had completed an investigation, brought an enforcement action and then settled it. |
National Defense November 2010 Marinelli & Latour |
Vetting Partners: A Key Compliance Element Vetting vendors and other partners is a critical element of a comprehensive export compliance program. |
The Motley Fool July 13, 2011 Jonathan Berr |
Rupert Murdoch's Never-Ending Headache A $5 billion share buyback won't calm outraged investors as a possible federal inquiry looms. |
Financial Planning January 5, 2008 Max Mejiborsky |
Compliance A string of recent administrative proceedings have revealed that recidivism continues to plague the investment advisor community, despite an increased emphasis on compliance and the SEC's Compliance Programs Rule. |
The Motley Fool March 8, 2004 Rich Smith |
Titanic Troubles for Lockheed? Lockheed's acquisition target, Titan, may be in trouble with the Feds. |
The Motley Fool December 7, 2004 Rich Smith |
InVision Sees End of Tunnel A Department of Justice settlement for violations of the U.S. Foreign Corrupt Practices Act (FCPA) clears the way for acquisition of the tiny bomb detector by GE. |
CFO October 1, 2002 Alix Nyberg |
Regulation: Pitt and the Pendulum The kinder, gentler SEC Pitt envisioned vanished faster than you can say Arthur Andersen. Can he run a tougher, meaner agency? |
CFO April 1, 2003 Kris Frieswick |
Fraud Squad Federal investigators are on a crusade to elevate corporate misdeeds to criminal offenses. |
CFO April 1, 2006 John Goff |
Coming Distractions As big a concern as E-waste is, it is still only a small bite in the larger risk grid confronting business managers these days. Here are eight risks managers need to focus on. Green Laws: No Hazmats Beyond This Point... Terrorism Insurance: Duck and Cover... etc. |
The Motley Fool April 7, 2004 Rich Smith |
Lucent Sings to the Feds The company discovers further instances of possible bribery by its employees, this time in China. |
Entrepreneur September 2004 Jane Easter Bahls |
Illicit Affairs? If you do business overseas, be certain your "administrative fees" aren't really illegal bribes. And because complying with the many overlapping laws is tricky, hire a lawyer with experience in international business. |
CFO July 15, 2011 Kimberly Blanton |
Creating a Culture of Compliance "Tone at the top" is an overused phrase, but if companies want to mitigate fraud senior leaders need to speak up forcefully. |
Managed Care May 2007 |
Compensation Monitor Most docs break bread with pharma. |
Investment Advisor October 2007 Melanie Waddell |
Making Compliance Headway Four years after the passage of the SEC's "compliance program rule," advisors are still grappling with exactly what their annual review process should entail. |
CFO March 1, 2004 Kris Frieswick |
Bar Hopping Already considered one of the most severe civil penalties for securities violations, officer and director (O/D) bars have been embraced by the Securities and Exchange Commission with a new zeal. |
Pharmaceutical Executive June 1, 2007 Jack Schember |
Sales Management: Cleaning House A well-maintained database is the key to maximum doctor outreach. |
Pharmaceutical Executive December 1, 2010 William Looney |
Is Euroland Following the US Disclosure Lead? Cegedim Relationship Management survey documents whether European industry is ready for the challenge of new compliance and disclosure risks on promotional spending. |